Rapid Micro Biosystems (RPID) Competitors

$2.54 -0.04 (-1.36%)

As of 10:59 AM Eastern

RPID vs. NAUT, LAB, OPTX, PRE, and MASS

Should you be buying Rapid Micro Biosystems stock or one of its competitors? The main competitors of Rapid Micro Biosystems include Nautilus Biotechnology (NAUT), Standard BioTools (LAB), Syntec Optics (OPTX), Prenetics Global (PRE), and 908 Devices (MASS). These companies are all part of the "measuring and control equipment" industry.

How does Rapid Micro Biosystems compare to Nautilus Biotechnology?

Nautilus Biotechnology (NASDAQ:NAUT) and Rapid Micro Biosystems (NASDAQ:RPID) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, media sentiment, profitability, risk, institutional ownership and analyst recommendations.

Nautilus Biotechnology has a net margin of 0.00% compared to Rapid Micro Biosystems' net margin of -140.30%. Nautilus Biotechnology's return on equity of -35.04% beat Rapid Micro Biosystems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nautilus Biotechnology	N/A	-35.04%	-29.16%
Rapid Micro Biosystems	-140.30%	-95.40%	-58.85%

Rapid Micro Biosystems has higher revenue and earnings than Nautilus Biotechnology. Nautilus Biotechnology is trading at a lower price-to-earnings ratio than Rapid Micro Biosystems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nautilus Biotechnology	N/A	N/A	-$59M	-$0.46	N/A
Rapid Micro Biosystems	$33.59M	3.44	-$47.12M	-$1.07	N/A

In the previous week, Nautilus Biotechnology and Nautilus Biotechnology both had 3 articles in the media. Nautilus Biotechnology's average media sentiment score of 1.23 beat Rapid Micro Biosystems' score of 0.56 indicating that Nautilus Biotechnology is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Nautilus Biotechnology	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Rapid Micro Biosystems	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Nautilus Biotechnology presently has a consensus price target of $4.00, suggesting a potential upside of 37.22%. Rapid Micro Biosystems has a consensus price target of $8.00, suggesting a potential upside of 214.34%. Given Rapid Micro Biosystems' higher possible upside, analysts plainly believe Rapid Micro Biosystems is more favorable than Nautilus Biotechnology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nautilus Biotechnology	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Rapid Micro Biosystems	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

50.7% of Nautilus Biotechnology shares are owned by institutional investors. Comparatively, 52.6% of Rapid Micro Biosystems shares are owned by institutional investors. 41.1% of Nautilus Biotechnology shares are owned by company insiders. Comparatively, 12.7% of Rapid Micro Biosystems shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Nautilus Biotechnology has a beta of 0.75, indicating that its share price is 25% less volatile than the broader market. Comparatively, Rapid Micro Biosystems has a beta of 1.52, indicating that its share price is 52% more volatile than the broader market.

Summary

Nautilus Biotechnology and Rapid Micro Biosystems tied by winning 6 of the 12 factors compared between the two stocks.

How does Rapid Micro Biosystems compare to Standard BioTools?

Standard BioTools (NASDAQ:LAB) and Rapid Micro Biosystems (NASDAQ:RPID) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, risk, profitability, media sentiment, valuation, dividends, institutional ownership and analyst recommendations.

Standard BioTools currently has a consensus price target of $1.35, suggesting a potential upside of 36.09%. Rapid Micro Biosystems has a consensus price target of $8.00, suggesting a potential upside of 214.34%. Given Rapid Micro Biosystems' stronger consensus rating and higher probable upside, analysts plainly believe Rapid Micro Biosystems is more favorable than Standard BioTools.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Standard BioTools	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67
Rapid Micro Biosystems	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

53.7% of Standard BioTools shares are owned by institutional investors. Comparatively, 52.6% of Rapid Micro Biosystems shares are owned by institutional investors. 23.2% of Standard BioTools shares are owned by insiders. Comparatively, 12.7% of Rapid Micro Biosystems shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Rapid Micro Biosystems has lower revenue, but higher earnings than Standard BioTools. Rapid Micro Biosystems is trading at a lower price-to-earnings ratio than Standard BioTools, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Standard BioTools	$85.33M	4.54	-$74.90M	$0.20	4.96
Rapid Micro Biosystems	$33.59M	3.44	-$47.12M	-$1.07	N/A

Standard BioTools has a net margin of 73.46% compared to Rapid Micro Biosystems' net margin of -140.30%. Standard BioTools' return on equity of -8.18% beat Rapid Micro Biosystems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Standard BioTools	73.46%	-8.18%	-6.43%
Rapid Micro Biosystems	-140.30%	-95.40%	-58.85%

In the previous week, Standard BioTools had 2 more articles in the media than Rapid Micro Biosystems. MarketBeat recorded 5 mentions for Standard BioTools and 3 mentions for Rapid Micro Biosystems. Standard BioTools' average media sentiment score of 0.57 beat Rapid Micro Biosystems' score of 0.56 indicating that Standard BioTools is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Standard BioTools	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Rapid Micro Biosystems	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Standard BioTools has a beta of 1.32, suggesting that its stock price is 32% more volatile than the broader market. Comparatively, Rapid Micro Biosystems has a beta of 1.52, suggesting that its stock price is 52% more volatile than the broader market.

Summary

Standard BioTools beats Rapid Micro Biosystems on 11 of the 16 factors compared between the two stocks.

How does Rapid Micro Biosystems compare to Syntec Optics?

Syntec Optics (NASDAQ:OPTX) and Rapid Micro Biosystems (NASDAQ:RPID) are both small-cap measuring and control equipment companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, dividends, institutional ownership, earnings, valuation, media sentiment, profitability and analyst recommendations.

Syntec Optics has higher earnings, but lower revenue than Rapid Micro Biosystems. Syntec Optics is trading at a lower price-to-earnings ratio than Rapid Micro Biosystems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Syntec Optics	$28.08M	9.36	-$1.79M	-$0.05	N/A
Rapid Micro Biosystems	$33.59M	3.44	-$47.12M	-$1.07	N/A

52.6% of Rapid Micro Biosystems shares are held by institutional investors. 0.8% of Syntec Optics shares are held by company insiders. Comparatively, 12.7% of Rapid Micro Biosystems shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Syntec Optics has a net margin of -6.38% compared to Rapid Micro Biosystems' net margin of -140.30%. Syntec Optics' return on equity of -17.19% beat Rapid Micro Biosystems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Syntec Optics	-6.38%	-17.19%	-7.14%
Rapid Micro Biosystems	-140.30%	-95.40%	-58.85%

Rapid Micro Biosystems has a consensus price target of $8.00, suggesting a potential upside of 214.34%. Given Rapid Micro Biosystems' stronger consensus rating and higher possible upside, analysts plainly believe Rapid Micro Biosystems is more favorable than Syntec Optics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Syntec Optics	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Rapid Micro Biosystems	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, Rapid Micro Biosystems had 1 more articles in the media than Syntec Optics. MarketBeat recorded 3 mentions for Rapid Micro Biosystems and 2 mentions for Syntec Optics. Syntec Optics' average media sentiment score of 1.44 beat Rapid Micro Biosystems' score of 0.56 indicating that Syntec Optics is being referred to more favorably in the media.

Company	Overall Sentiment
Syntec Optics	Positive
Rapid Micro Biosystems	Positive

Syntec Optics has a beta of -0.93, suggesting that its stock price is 193% less volatile than the broader market. Comparatively, Rapid Micro Biosystems has a beta of 1.52, suggesting that its stock price is 52% more volatile than the broader market.

Summary

Rapid Micro Biosystems beats Syntec Optics on 9 of the 16 factors compared between the two stocks.

How does Rapid Micro Biosystems compare to Prenetics Global?

Rapid Micro Biosystems (NASDAQ:RPID) and Prenetics Global (NASDAQ:PRE) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, profitability, earnings, institutional ownership, valuation, dividends and risk.

Rapid Micro Biosystems has a beta of 1.52, suggesting that its share price is 52% more volatile than the broader market. Comparatively, Prenetics Global has a beta of 0.15, suggesting that its share price is 85% less volatile than the broader market.

Rapid Micro Biosystems currently has a consensus price target of $8.00, indicating a potential upside of 214.34%. Prenetics Global has a consensus price target of $32.33, indicating a potential upside of 85.40%. Given Rapid Micro Biosystems' higher possible upside, equities analysts clearly believe Rapid Micro Biosystems is more favorable than Prenetics Global.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Rapid Micro Biosystems	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Prenetics Global	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50

Prenetics Global has higher revenue and earnings than Rapid Micro Biosystems. Prenetics Global is trading at a lower price-to-earnings ratio than Rapid Micro Biosystems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Rapid Micro Biosystems	$33.59M	3.44	-$47.12M	-$1.07	N/A
Prenetics Global	$92.39M	3.18	-$37.71M	-$4.02	N/A

52.6% of Rapid Micro Biosystems shares are owned by institutional investors. Comparatively, 25.0% of Prenetics Global shares are owned by institutional investors. 12.7% of Rapid Micro Biosystems shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Prenetics Global had 4 more articles in the media than Rapid Micro Biosystems. MarketBeat recorded 7 mentions for Prenetics Global and 3 mentions for Rapid Micro Biosystems. Prenetics Global's average media sentiment score of 0.59 beat Rapid Micro Biosystems' score of 0.56 indicating that Prenetics Global is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Rapid Micro Biosystems	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Prenetics Global	1 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Prenetics Global has a net margin of -61.33% compared to Rapid Micro Biosystems' net margin of -140.30%. Prenetics Global's return on equity of -19.61% beat Rapid Micro Biosystems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Rapid Micro Biosystems	-140.30%	-95.40%	-58.85%
Prenetics Global	-61.33%	-19.61%	-15.33%

Summary

Prenetics Global beats Rapid Micro Biosystems on 9 of the 16 factors compared between the two stocks.

How does Rapid Micro Biosystems compare to 908 Devices?

908 Devices (NASDAQ:MASS) and Rapid Micro Biosystems (NASDAQ:RPID) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, media sentiment, dividends, risk, profitability, valuation and earnings.

908 Devices has a beta of 0.57, indicating that its stock price is 43% less volatile than the broader market. Comparatively, Rapid Micro Biosystems has a beta of 1.52, indicating that its stock price is 52% more volatile than the broader market.

88.1% of 908 Devices shares are owned by institutional investors. Comparatively, 52.6% of Rapid Micro Biosystems shares are owned by institutional investors. 28.2% of 908 Devices shares are owned by insiders. Comparatively, 12.7% of Rapid Micro Biosystems shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, 908 Devices had 11 more articles in the media than Rapid Micro Biosystems. MarketBeat recorded 14 mentions for 908 Devices and 3 mentions for Rapid Micro Biosystems. Rapid Micro Biosystems' average media sentiment score of 0.56 beat 908 Devices' score of 0.47 indicating that Rapid Micro Biosystems is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
908 Devices	3 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Rapid Micro Biosystems	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

908 Devices has a net margin of -62.40% compared to Rapid Micro Biosystems' net margin of -140.30%. 908 Devices' return on equity of -14.03% beat Rapid Micro Biosystems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
908 Devices	-62.40%	-14.03%	-10.40%
Rapid Micro Biosystems	-140.30%	-95.40%	-58.85%

908 Devices has higher revenue and earnings than Rapid Micro Biosystems. 908 Devices is trading at a lower price-to-earnings ratio than Rapid Micro Biosystems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
908 Devices	$56.20M	5.25	$19.49M	-$1.00	N/A
Rapid Micro Biosystems	$33.59M	3.44	-$47.12M	-$1.07	N/A

908 Devices presently has a consensus price target of $12.00, indicating a potential upside of 53.65%. Rapid Micro Biosystems has a consensus price target of $8.00, indicating a potential upside of 214.34%. Given Rapid Micro Biosystems' higher probable upside, analysts clearly believe Rapid Micro Biosystems is more favorable than 908 Devices.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
908 Devices	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50
Rapid Micro Biosystems	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

908 Devices beats Rapid Micro Biosystems on 11 of the 15 factors compared between the two stocks.

Get Rapid Micro Biosystems News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RPID and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

RPID vs. The Competition

Export

Metric	Rapid Micro Biosystems	MED INSTRUMENTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$115.70M	$6.79B	$6.24B	$12.14B
Dividend Yield	N/A	1.72%	2.78%	5.23%
P/E Ratio	-2.38	48.65	20.67	25.38
Price / Sales	3.44	60.68	547.41	75.53
Price / Cash	N/A	25.20	27.81	36.29
Price / Book	3.39	6.53	9.59	6.65
Net Income	-$47.12M	$158.34M	$3.54B	$333.19M
7 Day Performance	2.62%	-1.05%	-0.45%	-0.55%
1 Month Performance	20.05%	4.60%	5.68%	7.66%
1 Year Performance	-12.84%	-3.70%	38.47%	35.65%

Rapid Micro Biosystems Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
RPID Rapid Micro Biosystems	1.992 of 5 stars	$2.55 -1.4%	$8.00 +214.3%	-16.2%	$115.70M	$33.59M	N/A	200	Upcoming Earnings Analyst Downgrade
NAUT Nautilus Biotechnology	3.7345 of 5 stars	$2.86 -1.0%	$4.00 +39.9%	+331.4%	$367.26M	N/A	N/A	130	Positive News Gap Up
LAB Standard BioTools	2.8973 of 5 stars	$0.98 +4.7%	$1.35 +37.9%	-7.5%	$364.99M	$85.33M	N/A	620
OPTX Syntec Optics	1.0371 of 5 stars	$7.68 -5.0%	N/A	+426.4%	$298.91M	$28.08M	N/A	3	Positive News Short Interest Decrease
PRE Prenetics Global	2.7018 of 5 stars	$16.73 +1.4%	$32.33 +93.3%	+225.6%	$277.67M	$92.39M	N/A	1	Upcoming Earnings

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:RPID) was last updated on 5/12/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rapid Micro Biosystems (RPID) Competitors

RPID vs. NAUT, LAB, OPTX, PRE, and MASS

How does Rapid Micro Biosystems compare to Nautilus Biotechnology?

Summary

How does Rapid Micro Biosystems compare to Standard BioTools?

Summary

How does Rapid Micro Biosystems compare to Syntec Optics?

Summary

How does Rapid Micro Biosystems compare to Prenetics Global?

Summary

How does Rapid Micro Biosystems compare to 908 Devices?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RPID vs. The Competition

Rapid Micro Biosystems Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Rapid Micro Biosystems (RPID) Competitors

RPID vs. NAUT, LAB, OPTX, PRE, and MASS

How does Rapid Micro Biosystems compare to Nautilus Biotechnology?

Is NAUT or RPID more profitable?

Which has preferable valuation and earnings, NAUT or RPID?

Does the media prefer NAUT or RPID?

Do analysts prefer NAUT or RPID?

Do insiders & institutionals hold more shares of NAUT or RPID?

Which has more volatility & risk, NAUT or RPID?

Summary

How does Rapid Micro Biosystems compare to Standard BioTools?

Do analysts prefer LAB or RPID?

Do institutionals & insiders hold more shares of LAB or RPID?

Which has better earnings and valuation, LAB or RPID?

Is LAB or RPID more profitable?

Does the media prefer LAB or RPID?

Which has more risk & volatility, LAB or RPID?

Summary

How does Rapid Micro Biosystems compare to Syntec Optics?

Which has higher valuation & earnings, OPTX or RPID?

Do institutionals and insiders believe in OPTX or RPID?

Is OPTX or RPID more profitable?

Do analysts recommend OPTX or RPID?

Does the media refer more to OPTX or RPID?

Which has more volatility and risk, OPTX or RPID?

Summary

How does Rapid Micro Biosystems compare to Prenetics Global?

Which has more volatility & risk, RPID or PRE?

Do analysts recommend RPID or PRE?

Which has higher earnings and valuation, RPID or PRE?

Do insiders and institutionals believe in RPID or PRE?

Does the media favor RPID or PRE?

Is RPID or PRE more profitable?

Summary

How does Rapid Micro Biosystems compare to 908 Devices?

Which has more volatility & risk, MASS or RPID?

Do insiders & institutionals have more ownership in MASS or RPID?

Does the media refer more to MASS or RPID?

Is MASS or RPID more profitable?

Which has preferable valuation & earnings, MASS or RPID?

Do analysts rate MASS or RPID?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RPID vs. The Competition

Rapid Micro Biosystems Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools